Currently, there are 2.71B common shares owned by the public and among those 1.60B shares have been available to trade.
However, the script later moved the day high at 129.37, down -0.91%. The company’s stock has a 5-day price change of -1.38% and 17.94% over the past three months. ORCL shares are trading 17.94% year to date (YTD), with the 12-month market performance up to 37.38% higher. It has a 12-month low price of $92.09 and touched a high of $132.77 over the same period. ORCL has an average intraday trading volume of 9.13 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 1.32%, 6.27%, and 9.45% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Oracle Corp. (NYSE: ORCL) shares accounts for 43.88% of the company’s 2.71B shares outstanding.
It has a market capitalization of $341.75B and a beta (3y monthly) value of 1.01. The stock’s trailing 12-month PE ratio is 32.86, while the earnings-per-share (ttm) stands at $3.78. The company has a PEG of 2.97 and a Quick Ratio of 0.85 with the debt-to-equity ratio at 15.65. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.39% over the week and 2.06% over the month.
Earnings per share for the fiscal year are expected to increase by 9.14%, and 10.23% over the next financial year. EPS should shrink at an annualized rate of 11.06% over the next five years, compared to 29.43% over the past 5-year period.
Looking at the support for the ORCL, a number of firms have released research notes about the stock. KeyBanc Capital Markets stated their Overweight rating for the stock in a research note on March 21, 2024, with the firm’s price target at $150. William Blair was of a view on March 12, 2024 that the stock is Outperform, while BMO Capital Markets gave the stock Market Perform rating on March 12, 2024, issuing a price target of $126- $142. BMO Capital Markets on their part issued Market Perform rating on December 12, 2023.
